Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03684447

Neural and Antidepressant Effects of Propofol

Status
Active Not Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This study will compare the antidepressant effects of propofol at two different doses while measuring potential treatment-related biomarkers.

Detailed description

Aim 1: Compare the clinical antidepressant effects of high-dose versus low-dose propofol. Aim 2: Characterize the dose-dependent effects of propofol on brain function and gene expression

Conditions

Interventions

TypeNameDescription
DRUGPropofolSeries of 6 treatments with propofol.
DRUGPropofolSeries of 6 treatments with propofol. May be able to cross over and receive 6 additional treatments with the high dose of propofol.

Timeline

Start date
2019-04-21
Primary completion
2022-12-31
Completion
2024-07-01
First posted
2018-09-25
Last updated
2024-05-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03684447. Inclusion in this directory is not an endorsement.

Neural and Antidepressant Effects of Propofol (NCT03684447) · Clinical Trials Directory